SCHEMBL15670429

SCHEMBL15670429

Cc1nc2c(OCc3ccccc3)cccn2c1OC(=O)O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATP4A P20648 3/20 0.65
ATP4B P51164 3/20 0.65
CYP1A2 P05177 2/20 0.60
CYP3A4 P08684 2/20 0.60
CYP2D6 P10635 2/20 0.60
CYP2C9 P11712 2/20 0.60
MEN1 O00255 1/20 0.60
MAPK1 P28482 1/20 0.60
BLM P54132 1/20 0.60
PMP22 Q01453 1/20 0.60
KMT2A Q03164 1/20 0.60
HDAC6 Q9UBN7 1/20 0.60
PSEN1 P49768 12/20 0.53
PSEN2 P49810 12/20 0.53
APH1B Q8WW43 12/20 0.53
NCSTN Q92542 12/20 0.53
APH1A Q96BI3 12/20 0.53
PSENEN Q9NZ42 12/20 0.53
CYP2C19 P33261 1/20 0.47
GUCY1B2 O75343 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15670130 0.84 GUCY1B2 (0.61) GUCY1B2GUCY1A2GUCY1A1GUCY1B1
SCHEMBL18783595 0.84 ATP4A (0.48) ATP4AATP4BCYP1A2CYP3A4CYP2D6
SCHEMBL11064908 0.83 ATP4A (0.68) ATP4AATP4BCYP1A2CYP3A4CYP2D6
SCHEMBL15671382 0.82 GUCY1B2 (0.52) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL15671365 0.82 GUCY1B2 (0.58) ATP4AATP4BGUCY1B2GUCY1A2GUCY1A1
SCHEMBL15609152 0.81 ATP4A (0.68) ATP4AATP4BCYP1A2CYP3A4CYP2D6
SCHEMBL11064550 0.81 ATP4A (0.76) ATP4AATP4BCYP1A2CYP3A4CYP2D6
SCHEMBL2193469 0.81 ATP4A (0.76) ATP4AATP4BCYP1A2CYP3A4CYP2D6
SCHEMBL8816284 0.80 ATP4A (0.74) ATP4AATP4BCYP1A2CYP3A4CYP2D6
SCHEMBL15670670 0.80 GUCY1B2 (0.57) GUCY1B2GUCY1A2GUCY1A1GUCY1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3272749-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE AS STIMULATORS OF SOLUBLE GUANYLATE CYCLASE Bayer Pharma Aktiengesellschaft (DE) 2018-01-24 EP disclosed
EP-3107920-B1 3-(PYRIMIDINE-2-YL)IMIDAZO[1,2-A]PYRIDINES Bayer Pharma AG (DE) 2017-10-18 EP disclosed
EP-2914596-B1 HYDROXY SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE CARBOXAMIDES AND THEIR USE AS STIMULATORS OF SOLUBLE GUANYLATE CYCLASE Bayer Pharma AG (DE) 2017-06-21 EP disclosed
EP-2914594-B1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE Bayer Pharma AG (DE) 2017-05-03 EP disclosed
EP-3107920-A1 3-(PYRIMIDINE-2-YL)IMIDAZO[1,2-A]PYRIDINES Bayer Pharma Aktiengesellschaft (DE) 2016-12-28 EP disclosed
EP-2914594-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE Bayer Pharma Aktiengesellschaft (DE) 2015-09-09 EP disclosed
EP-2914596-A1 HYDROXY-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE AS SOLUBLE GUANYLATE CYCLASE STIMULANTS Bayer Pharma Aktiengesellschaft (DE) 2015-09-09 EP disclosed
WO-2015124544-A1 3-(PYRIMIDINE-2-YL)IMIDAZO[1,2-A]PYRIDINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-08-27 WO disclosed
WO-2014068099-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-05-08 WO disclosed
WO-2014068104-A1 HYDROXY-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE AS SOLUBLE GUANYLATE CYCLASE STIMULANTS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-05-08 WO disclosed